Open Access

Table 1

Association of adjuvant chemotherapy with clinical variables in the patients with localized dedifferentiated chondrosarcoma.

Adjuvant chemotherapy
Variable No. of patients (n = 98) No (n = 78) Yes (n = 20) P value
Age (years), n (%) 0.019*
  < 40 2 (2.0) 1 (1.3) 1 (5.0)
 40–65 40 (40.8) 27 (34.6) 13 (65.0)
  > 65 56 (57.1) 50 (64.1) 6 (30.0)
Sex, n (%) 0.776
 Male 61 (62.2) 48 (61.5) 13 (65.0)
 Female 37 (37.8) 30 (38.5) 7 (35.0)
Previous surgery, n (%) 0.339#
 No 91 (92.9) 71 (91.0) 20 (100)
 Yes 7 (7.1) 7 (9.0) 0 (0)
Site, n (%) 0.156
 Trunk 41 (41.8) 29 (37.2) 12 (60.0)
 Upper limb 20 (20.4) 18 (23.1) 2 (10.0)
 Lower limb 37 (37.8) 31 (39.7) 6 (30.0)
Tumor size (cm), n (%) 0.145#
  < 8 23 (23.5) 21 (26.9) 2 (10.0)
  ≥ 8 75 (76.5) 57 (73.1) 18 (90.0)
Biopsy, n (%) 0.274
 None 10 (10.2) 9 (11.5) 1 (5.0)
 Needle 6 (6.1) 6 (7.7) 0
 Open 82 (83.7) 63 (80.8) 19 (95.0)
Surgical margin, n (%) 0.988
 R0 70 (71.4) 56 (71.8) 14 (70.0)
 R1 or R2 14 (14.3) 11 (14.1) 3 (15.0)
 No surgery 14 (14.3) 11 (14.1) 3 (15.0)
Adjuvant radiotherapy, n (%) 0.113#
 No 87 (88.8) 67 (85.9) 20 (100)
 Yes 11 (11.2) 11 (14.1) 0
Local recurrence, n (%) 0.602#
 No 67 (77.0) 53 (76.8) 14 (77.8)
 Yes 20 (23.0) 16 (23.2) 4 (22.2)
Distant metastases, n (%) 0.361
 No 45 (45.9) 34 (43.6) 11 (55.0)
 Yes 53 (54.1) 44 (56.4) 9 (45.0)
Died of disease, n (%) 0.316
 No 49 (50.0) 37 (47.4) 12 (60.0)
 Yes 49 (50.0) 41 (52.6) 8 (40.0)
Follow-up period after diagnosis (months), median (IQR) 14.5 (5.8–36.8) 11 (4–34.6) 25 (11.5–59.8) 0.023*
*

Statistically significant.

#

Fisher exact test was used.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.